AAV.php.eb-husod1-sgrna

AAV.php.eb-husod1-sgrna has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 1, 2022: “In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on AAV.php.eb-husod1-sgrna

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Biogen
  • 1 of 1 finding with company ties
  • Animals1

What did studies of AAV.php.eb-husod1-sgrna find?

1

Studies of AAV.php.eb-husod1-sgrna measured one outcome, lifespan.

Lifespan

upin mice1

1 study
  1. AAV.php.eb-husod1-sgrna extends lifespan in adult H11Cas9 SOD1G93A mice, immediately before symptom onset (>=170 days).

    “also extended lifespan by at least 170 days”

    Animalsin adult H11Cas9 SOD1G93A mice, immediately before symptom onsetintrathecal or intravenous injection

    In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

    Gene therapy

Latest